As of 2025-03-23, the Relative Valuation of Ionis Pharmaceuticals Inc (IONS) is (42.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.91 USD, the upside of Ionis Pharmaceuticals Inc based on Relative Valuation is -228.8%.
The range of the Relative Valuation is (39.69) - (44.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 16.4x | 15.3x |
| Forward P/E multiples | 13.2x - 15.4x | 14.4x |
| Fair Price | (39.69) - (44.09) | (42.40) |
| Upside | -220.6% - -234.0% | -228.8% |
| Date | P/E |
| 2025-03-14 | -11.54 |
| 2025-03-13 | -11.52 |
| 2025-03-12 | -11.70 |
| 2025-03-11 | -11.57 |
| 2025-03-10 | -11.28 |
| 2025-03-07 | -11.84 |
| 2025-03-06 | -12.04 |
| 2025-03-05 | -11.82 |
| 2025-03-04 | -11.54 |
| 2025-03-03 | -11.42 |
| 2025-02-28 | -11.62 |
| 2025-02-27 | -10.98 |
| 2025-02-26 | -11.12 |
| 2025-02-25 | -11.15 |
| 2025-02-24 | -11.17 |
| 2025-02-21 | -11.32 |
| 2025-02-20 | -11.45 |
| 2025-02-19 | -11.14 |
| 2025-02-18 | -11.19 |
| 2025-02-14 | -10.87 |
| 2025-02-13 | -10.63 |
| 2025-02-12 | -10.80 |
| 2025-02-11 | -11.06 |
| 2025-02-10 | -11.02 |
| 2025-02-07 | -11.00 |
| 2025-02-06 | -11.43 |
| 2025-02-05 | -11.62 |
| 2025-02-04 | -11.08 |
| 2025-02-03 | -11.25 |
| 2025-01-31 | -11.17 |
| 2025-01-30 | -11.67 |
| 2025-01-29 | -11.51 |
| 2025-01-28 | -11.95 |
| 2025-01-27 | -11.92 |
| 2025-01-24 | -12.17 |
| 2025-01-23 | -12.07 |
| 2025-01-22 | -11.38 |
| 2025-01-21 | -11.44 |
| 2025-01-17 | -11.01 |
| 2025-01-16 | -11.30 |
| 2025-01-15 | -11.63 |
| 2025-01-14 | -11.45 |
| 2025-01-13 | -12.24 |
| 2025-01-10 | -11.72 |
| 2025-01-08 | -11.94 |
| 2025-01-07 | -12.25 |
| 2025-01-06 | -11.94 |
| 2025-01-03 | -12.19 |
| 2025-01-02 | -12.15 |
| 2024-12-31 | -12.24 |